{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T12:41:54Z","timestamp":1787402514734,"version":"build-2736575974"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Development of next-generation sequencing (NGS) has provided useful genetic information to redefine diagnostic, prognostic, and therapeutic strategies for the management of acute leukemia (AL). However, the application in the clinical setting is still challenging. Our aim was to validate the AmpliSeq\u2122 for Illumina\u00ae Childhood Cancer Panel, a pediatric pan-cancer targeted NGS panel that includes the most common genes associated with childhood cancer, and assess its utility in the daily routine of AL diagnostics. In terms of sequencing metrics, the assay reached all the expected values. We obtained a mean read depth greater than 1000\u00d7. The panel demonstrated a high sensitivity for DNA (98.5% for variants with 5% variant allele frequency (VAF)) and RNA (94.4%), 100% of specificity and reproducibility for DNA and 89% of reproducibility for RNA. Regarding clinical utility, 49% of mutations and 97% of the fusions identified were demonstrated to have clinical impact. Forty-one percent of mutations refined diagnosis, while 49% of them were considered targetable. Regarding RNA, fusion genes were more clinically impactful in terms of refining diagnostic (97%). Overall, the panel found clinically relevant results in the 43% of patients tested in this cohort. To sum up, we validated a reliable and reproducible method to refine pediatric AL diagnosis, prognosis, and treatment, and demonstrated the feasibility of incorporating a targeted NGS panel into pediatric hematology practice.<\/jats:p>","DOI":"10.3389\/fmolb.2022.854098","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T05:54:59Z","timestamp":1649310899000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia"],"prefix":"10.3389","volume":"9","author":[{"given":"Clara","family":"Vicente-Garc\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Esperanza-Cebollada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Montesdeoca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Torrebadell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Rives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Dapena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Catal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Cam\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Vega-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jmoldx.2018.09.009","article-title":"Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics","volume":"21","author":"Alonso","year":"2019","journal-title":"J. Mol. Diagn."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 Revision to the World Health Organization Classification of Myeloid Neoplasms and Acute Leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood Am. Soc. Hematol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/17474086.2020.1685866","article-title":"Recent Advances in Genetic Predisposition to Pediatric Acute Lymphoblastic Leukemia","volume":"13","author":"Bloom","year":"2020","journal-title":"Expert Rev. Hematol. [Internet]. Expert Rev. Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nm.4439","article-title":"The Molecular Landscape of Pediatric Acute Myeloid Leukemia Reveals Recurrent Structural Alterations and Age-specific Mutational Interactions","volume":"24","author":"Bolouri","year":"2017","journal-title":"Nat. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3390\/cancers11091364","article-title":"Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms","volume":"11","author":"Carbonell","year":"2019","journal-title":"Cancers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20122929","article-title":"Next-generation Sequencing in Acute Lymphoblastic Leukemia","volume":"2020","author":"Coccaro","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11912-020-01009-3","article-title":"Acute Myeloid Leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy","volume":"23","author":"Conneely","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0149405","article-title":"Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material","volume":"11","author":"De Leng","year":"2016","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2017.00252","article-title":"Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago Experience [Internet]","volume-title":"Front. Pediatr.","author":"Desai","year":""},{"key":"B10","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/nm.4410","article-title":"Clonal Evolution in Leukemia","volume":"23","author":"Ferrando","year":"2017","journal-title":"Nat. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and Quality Control Studies of 'real-Time' Quantitative Reverse Transcriptase Polymerase Chain Reaction of Fusion Gene Transcripts for Residual Disease Detection in Leukemia - A Europe against Cancer Program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1182\/blood-2007-08-109090","article-title":"The Impact of FLT3 Internal Tandem Duplication Mutant Level, Number, Size, and Interaction with NPM1 Mutations in a Large Cohort of Young Adult Patients with Acute Myeloid Leukemia. Blood [Internet]","volume":"111","author":"Gale","year":"2008","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3324\/haematol.2012.071597","article-title":"Survival and Cure Trends for European Children, Adolescents and Young Adults Diagnosed with Acute Lymphoblastic Leukemia from 1982 to 2002","volume":"98","author":"Gatta","year":"2013","journal-title":"Haematologica"},{"key":"B14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1182\/blood-2015-07-604496","article-title":"Molecular Landscape of Acute Myeloid Leukemia in Younger Adults and its Clinical Relevance","volume":"127","author":"Grimwade","year":"2016","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The Landscape of Genomic Alterations across Childhood Cancers","volume":"555","author":"Gr\u00f6bner","year":"2018","journal-title":"Nat. [Internet]"},{"key":"B16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jmoldx.2018.06.009","article-title":"OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric Malignancies. J Mol Diagn [Internet]","volume":"20","author":"Hiemenz","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"B17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00428-017-2288-7","article-title":"Multicenter Validation of Cancer Gene Panel-Based Next-Generation Sequencing for Translational Research and Molecular Diagnostics","volume":"472","author":"Hirsch","year":"2018","journal-title":"Virchows Arch."},{"key":"B18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The Genomic Landscape of Hypodiploid Acute Lymphoblastic Leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/nejmra1400972","article-title":"Acute Lymphoblastic Leukemia in Children","volume":"373","author":"Hunger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B20","unstructured":"Haematologica. Ferrata Storti Foundation; 2020. Pediatr. acute lymphoblastic Leuk. [Internet]25242539\n            InabaH.\n            MullighanC. G.\n          2020"},{"key":"B21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00277-018-3554-8","article-title":"Panel-based Next-Generation Sequencing Identifies Prognostic and Actionable Genes in Childhood Acute Lymphoblastic Leukemia and Is Suitable for Clinical Sequencing","volume":"98","author":"Ishida","year":"2019","journal-title":"Ann. Hematol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jmoldx.2019.10.002","article-title":"Clinical Validation of a Myeloid Next-Generation Sequencing Panel for Single-Nucleotide Variants, Insertions\/Deletions, and Fusion Genes","volume":"22","author":"Izevbaye","year":"2020","journal-title":"J. Mol. Diagn."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1038\/sj.leu.2403939","article-title":"Efficient and Easy Detection of MLL-AF4, MLL-AF9 and MLL-ENL Fusion Gene Transcripts by Multiplex Real-Time Quantitative RT-PCR in TaqMan and LightCycler","volume":"19","author":"Jansen","year":"2021","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jmoldx.2017.01.011","article-title":"Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels","volume":"19","author":"Jennings","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"B25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/leu.2017.303","article-title":"RAS Pathway Mutations as a Predictive Biomarker for Treatment Adaptation in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"32","author":"Jerchel","year":"2018","journal-title":"Leukemia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/moh.0000000000000626","article-title":"Genetic Heterogeneity and Clonal Evolution in Acute Myeloid Leukemia","volume":"28","author":"Js","year":"2021","journal-title":"Curr. Opin. Hematol. [Internet]. Curr. Opin. Hematol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute Myeloid Leukemia: Current Progress and Future Directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41568-020-00315-z","article-title":"Advances in Germline Predisposition to Acute Leukaemias and Myeloid Neoplasms","volume":"21","author":"Klco","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1182\/blood-2002-02-0420","article-title":"Studies of FLT3 Mutations in Paired Presentation and Relapse Samples from Patients with Acute Myeloid Leukemia: Implications for the Role of FLT3 Mutations in Leukemogenesis, Minimal Residual Disease Detection, and Possible Therapy with FLT3 Inhibitors","volume":"100","author":"Kottaridis","year":"2002","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1182\/hematology.2020006910","article-title":"Identifying Potential Germline Variants from Sequencing Hematopoietic Malignancies","volume":"2020","author":"Kraft","year":"2020","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer","volume":"19","author":"Li","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"B32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/humu.22719","article-title":"The Mutational Landscape in Pediatric Acute Lymphoblastic Leukemia Deciphered by Whole Genome Sequencing","volume":"36","author":"Lindqvist","year":"2015","journal-title":"Hum. Mutat."},{"key":"B33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/pgpm.s239602","article-title":"Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia [Internet]","volume":"13","author":"Maamari","year":"2020","journal-title":"Pharmacogenomics Personalized Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/leu.2013.339","article-title":"Core-binding Factor Acute Myeloid Leukemia in Pediatric Patients Enrolled in the AIEOP AML 2002\/01 Trial: Screening and Prognostic Impact of C-KIT Mutations","volume":"28","author":"Manara","year":"2021","journal-title":"Leukemia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s11899-017-0376-z","article-title":"Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children with Acute Lymphoblastic Leukemia","volume":"12","author":"Maxwell","year":"2017","journal-title":"Curr. Hematol. Malig Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/sj.leu.2401723","article-title":"Genetic Polymorphism of Thiopurine Methyltransferase and its Clinical Relevance for Childhood Acute Lymphoblastic Leukemia","volume":"14","author":"McLeod","year":"2000","journal-title":"Leukemia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/bjh.14823","article-title":"Acute Myeloid Leukaemia Genomics","volume":"179","author":"Medinger","year":"2017","journal-title":"Br. J. Haematolblackwell Publishing Ltd"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1182\/blood-2013-08-460311","article-title":"Genome Sequencing of Lymphoid Malignancies","volume":"122","author":"Mullighan","year":"2013","journal-title":"Blood [Internet]"},{"key":"B39","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide Analysis of Genetic Alterations in Acute Lymphoblastic Leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"B40","first-page":"2754","article-title":"Mutational Spectrum of Adult T-ALL","volume-title":"Oncotarget","author":"Neumann","year":""},{"key":"B41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13073-016-0389-6","article-title":"Implementation of Next Generation Sequencing into Pediatric Hematology-Oncology Practice: Moving beyond Actionable Alterations","volume":"8","author":"Oberg","year":"2021","journal-title":"Genome Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.beha.2018.09.014","article-title":"Identifying Patients with Genetic Predisposition to Acute Myeloid Leukemia","volume":"31","author":"Obrochta","year":"2018","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"11306","DOI":"10.1073\/pnas.1608420113","article-title":"Mutational Landscape, Clonal Evolution Patterns, and Role of RAS Mutations in Relapsed Acute Lymphoblastic Leukemia","volume":"113","author":"Oshima","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/ng.3301","article-title":"The Genomic Landscape of High Hyperdiploid Childhood Acute Lymphoblastic Leukemia","volume":"47","author":"Paulsson","year":"2015","journal-title":"Nat. Genet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11684-020-0759-8","article-title":"Precision Medicine in Acute Lymphoblastic Leukemia","volume":"14","author":"Pui","year":"2020","journal-title":"Front. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/genes12060924","article-title":"Cytogenetics of Pediatric Acute Myeloid Leukemia: A Review of the Current Knowledge","volume":"11","author":"Quessada","year":"2021","journal-title":"Genes (Basel)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1182\/blood-2002-11-3599","article-title":"Mutations in Exon 2 of GATA1 Are Early Events in Megakaryocytic Malignancies Associated with Trisomy 21","volume":"102","author":"Rainis","year":"2003","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1097\/HS9.0000000000000053","article-title":"Advances in B-Cell Precursor Acute Lymphoblastic Leukemia Genomics","volume":"2","author":"Schwab","year":"2018","journal-title":"HemaSphere"},{"key":"B51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.leukres.2017.09.012","article-title":"Emerging Role of NUDT15 Polymorphisms in 6-mercaptopurine Metabolism and Dose Related Toxicity in Acute Lymphoblastic Leukaemia","volume":"62","author":"Singh","year":"2017","journal-title":"Leuk. Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13073-019-0644-8","article-title":"Clinical Utility of Custom-Designed NGS Panel Testing in Pediatric Tumors","volume":"11","author":"Surrey","year":"2021","journal-title":"Genome Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/ni.3160","article-title":"Mechanisms of Clonal Evolution in Childhood Acute Lymphoblastic Leukemia","volume":"16","author":"Swaminathan","year":"2015","journal-title":"Nat. Immunol."},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2020.10.013","volume-title":"The Genomic Landscape of Pediatric Acute Lymphoblastic Leukemia and Precision Medicine Opportunities","author":"Tran","year":"2020"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm10040244","article-title":"Helpful Criteria when Implementing Ngs Panels in Childhood Lymphoblastic Leukemia","volume":"10","author":"Vega-Garcia","year":"2020","journal-title":"J. Pers Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer Genome Landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","first-page":"8457","DOI":"10.1002\/cam4.3467","article-title":"Characteristics and Prognostic Significance of Genetic Mutations in Acute Myeloid Leukemia Based on a Targeted Next-Generation Sequencing Technique","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1515\/jtim-2016-0040","article-title":"2016 Revision to the WHO Classification of Acute Lymphoblastic Leukemia","volume":"4","author":"Wang","year":"2016","journal-title":"J. Transl Intern. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"12484","DOI":"10.1038\/ncomms12484","article-title":"Clonal Haematopoiesis Harbouring AML-Associated Mutations Is Ubiquitous in Healthy Adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.854098\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T05:55:12Z","timestamp":1649310912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.854098\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":59,"alternative-id":["10.3389\/fmolb.2022.854098"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.854098","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"article-number":"854098"}}